 Liminal BioSciences Inc. NASDAQ: LMNL TSX: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company today announced that Kenneth Galbraith, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview at Raymond James Human Health Innovation Conference on Thursday 18th June at 13:00 EDT. 